切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (03) : 178 -182. doi: 10.3877/cma.j.issn.2095-3232.2014.03.012

所属专题: 文献

基础研究

活化态肝星状细胞调控肝细胞癌微血管形成的机制
李龑杼1, 林楠1, 卢逸1, 朱冰1, 许瑞云1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝胆外科
  • 收稿日期:2014-03-07 出版日期:2014-06-10
  • 通信作者: 许瑞云
  • 基金资助:
    国家自然科学基金(81272642)

Regulatory mechanism of activated hepatic stellate cell in the microvascular generation of hepatocellular carcinoma

Yanzhu Li1, Nan Lin1, Yi Lu1, Bing Zhu1, Ruiyun Xu1,()   

  1. 1. Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2014-03-07 Published:2014-06-10
  • Corresponding author: Ruiyun Xu
  • About author:
    Corresponding author: Xu Ruiyun, Email:
引用本文:

李龑杼, 林楠, 卢逸, 朱冰, 许瑞云. 活化态肝星状细胞调控肝细胞癌微血管形成的机制[J]. 中华肝脏外科手术学电子杂志, 2014, 03(03): 178-182.

Yanzhu Li, Nan Lin, Yi Lu, Bing Zhu, Ruiyun Xu. Regulatory mechanism of activated hepatic stellate cell in the microvascular generation of hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(03): 178-182.

目的

探讨活化态肝星状细胞(aHSC)调控肝细胞癌(肝癌)微血管形成的机制。

方法

组织标本来源于2013年1月至12月在中山大学附属第三医院肝胆外科行肝切除术的25例肝癌患者。所有患者均签署知情同意书,符合医学伦理学规定。其中男21例,女4例;年龄29~75岁,中位年龄54岁。分别取肝癌组织(肝癌组)、癌旁组织(癌旁组),同时选取21例正常肝组织作对照组。免疫组织化学方法(免疫组化法)检测平滑肌肌动蛋白(SMA)、血管生成素(Ang) -1、分化群(CD)34表达。蛋白质印迹法(Western blot)检测Ang-1表达水平。肝癌组织SMA高表达为aHSC的标志。3组比较采用单因素方差分析和LSD-t检验。蛋白表达的相关性采用Spearman相关分析。

结果

肝癌组、癌旁组和对照组SMA平均光密度值分别为(4.56±0.64)×104、(2.71±0.37)×104、(2.25±0.48)×104,肝癌组明显高于癌旁组和对照组(LSD-t=7.09,7.42;P<0.05)。3组Ang-1光密度值分别为(3.11±0.27)×105、(2.28±0.20)×105、(1.26±0.15)×105,肝癌组明显高于癌旁组和对照组(LSD-t=3.00,3.14;P<0.05)。3组Ang-1表达相对灰度值分别4.33±1.17、1.62±0.33、1.60±0.38,肝癌组明显高于癌旁组和对照组(LSD-t=2.71,2.74;P<0.05)。3组CD34光密度值分别为(18.30±0.36)×103、(5.75±1.17)×103、(2.75±0.72)×103,肝癌组明显高于癌旁组和对照组(LSD-t=3.21,3.36;P<0.05)。SMA与Ang-1、CD34,Ang-1与CD34两两之间均呈正相关(r= 0.442,0.449,0.582;P<0.05)。

结论

肝癌组织中SMA、Ang-1、CD34呈高表达,且三者密切相关。肝癌组织中存在SMA标记的aHSC,aHSC可能通过分泌Ang-1促进肝癌微血管形成。

Objective

To investigate the regulatory mechanism of activated hepatic stellate cell (aHSC) in the microvascular generation of hepatocellular carcinoma (HCC).

Methods

Tissue samples of 25 patients with HCC who underwent liver resection in Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Sun Yat-sen University from January to December 2013 were collected. The informed consents of all patients were obtained and the ethical committee approval was received. There were 21 males and 4 females with age ranging from 29 to 75 years old and the median age of 54 years old. The HCC tissues (HCC group) and peri-cancer tissues (peri-cancer group) were collected and normal liver tissues of 21 cases were collected as control group. The expressions of smooth muscle actin (SMA), angiogenin (Ang-1), and cluster of differentiation (CD) 34 were detected by immunohistochemistry. The expression level of Ang-1 was detected by Western blot. The high expression of SMA in HCC tissues was regarded as a marker of aHSC. The differences of 3 groups were compared using one-way analysis of variance and LSD-t test. Spearman correlation analysis was used to analyze the correlations between different proteins expression.

Results

The mean of optical densities of SMA in HCC, peri-cancer, control group were (4.56±0.64)×104, (2.71±0.37)×104, (2.25±0.48)×104 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=7.09, 7.42; P<0.05). The optical densities of Ang-1 in 3 groups were (3.11±0.27)×105, (2.28±0.20)×105, (1.26±0.15)×105 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=3.00, 3.14; P<0.05). The relative gray values of Ang-1 expression in 3 groups were 4.33±1.17, 1.62±0.33, 1.60±0.38 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=2.71, 2.74; P<0.05). The optical intensities of CD34 in 3 groups were (18.3±0.36)×103, (5.75±1.17)×103, (2.75±0.72)×103 respectively, which was significantly higher in HCC group than those in peri-cancer group and control group (LSD-t=3.21, 3.36; P<0.05). There were positive correlations between SMA, Ang-1, CD34 (r=0.442, 0.449, 0.582; P<0.05).

Conclusions

High expressions of SMA, Ang-1 and CD34 can be observed in HCC group and closely related with each other. SMA marked aHSC can be observed in the HCC tissues. The aHSC may promote the microvascular generation of HCC by secreting Ang-1.

图1 三组组织中平滑肌肌动蛋白的表达
图2 三组组织中血管生成素-1的表达
图3 三组组织中分化群34的表达
[1]
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
[2]
Jia YL, Shi L, Zhou JN, et al. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focaladhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis[J]. Hepatology, 2011, 54(5):1808-1818.
[3]
Sancho-Bru P, Juez E, Moreno M, et al. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepaticstellate cells[J]. Liver Int, 2010, 30(1):31-41.
[4]
陈之巨,林楠,潘楚芝,等.活化态肝星状细胞对小鼠肝细胞肝癌血管形成、肿瘤生长及转移的作用[J/CD].中华肝脏外科手术学电子杂志,2013, 2(3):186-193.
[5]
Fernández M, Semela D, Bruix J, et al. Angiogenesis in liver disease[J]. J Hepatol, 2009, 50(3):604-620.
[6]
Sancho-Bru P, Juez E, Moreno M, et al. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepaticstellate cells[J]. Liver Int, 2010, 30(1):31-41.
[7]
Folkman J. Angiogenesis: an organizing principle for drug discovery? [J]. Nat Rev Drug Discov, 2007, 6(4):273-286.
[8]
Holopainen T, Huang H, Chen C, et al. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination andmetastasis establishment[J]. Cancer Res, 2009, 69(11):4656-4664.
[9]
Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system[J]. Nat Rev Mol Cell Biol, 2009, 10(3):165-177.
[10]
Ji Y, Wang Z, Li Z, et al. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells[J]. Cell Physiol Biochem, 2012, 29(5/6):863-874.
[11]
Huang H, Bhat A, Woodnutt G, et al. Targeting the ANGPT-TIE2 pathway in malignancy[J]. Nat Rev Cancer, 2010, 10(8):575-585.
[12]
Torimura T, Ueno T, Kin M, et al. Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma[J]. J Hepatol, 2004, 40(5):799-807.
[13]
Thomas M, Augustin HG. The role of the angiopoietins in vascular morphogenesis[J]. Angiogenesis, 2009, 12(2):125-137.
[14]
Huang J, Bae JO, Tsai JP, et al. Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade[J]. Int J Oncol, 2009, 34(1):79-87.
[15]
Holopainen T, Huang H, Chen C, et al. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment[J]. Cancer Res, 2009, 69(11):4656-4664.
[16]
Stoeltzing O, Ahmad SA, Liu W, et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors[J]. Cancer Res, 2003, 63(12):3370-3377.
[17]
Taura K, De Minicis S, Seki E, et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis[J]. Gastroenterology, 2008, 135(5):1729-1738.
[1] 李淼, 朱连华, 韩鹏, 姜波, 费翔. 高帧频超声造影评价肝细胞癌血管形态与风险因素的研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 911-915.
[2] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[3] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[4] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[5] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[6] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[7] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[8] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[9] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[10] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[11] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[12] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[13] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
[14] 吕瑶, 张婵, 陈建华, 张鸣青. 压力控制容量保证通气模式在腹腔镜肝细胞癌切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 528-533.
[15] 杨秀君, 崔梦莹, 张丹, 曲仙智, 苗云皓, 盛基尧, 郑戈, 刘水, 张学文. 信迪利单抗联合仑伐替尼成功转化治疗不可切除肝癌一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 581-584.
阅读次数
全文


摘要